Excipients

Pharmaceutical excipients, which can be functional or inactive ingredients, work to enhance the medically relevant properties of the API. When used to promote ingredient qualities, excipients can be an asset for formulators to increase stability, bulk up the formulation, or enhance the therapeutic effects of the API. Below you can explore helpful resources including editorial coverage and webinars related to pharmaceutical excipients.

  • Advances in Ionizable Lipid Design: Accelerating mRNA Therapeutic Development Through Rapid Optimization Platforms

    Recent breakthroughs in ionizable lipid engineering represent a paradigm shift in mRNA therapeutic development, transforming what was once a years-long optimization process into a matter of months. These advances center on sophisticated synthetic platforms that enable rapid generation and screening of diverse ionizable lipid libraries, coupled with... read more

  • Introduction to the World of Artificial Intelligence

    Artificial Intelligence (AI) is no longer just a concept confined to the pages of science fiction or the minds of theoretical thinkers. It has grown into a transformative force that is reshaping industries, societies, and even the way we perceive reality. The rise of AI has Figure 1. Introduction to the World of Artificial Intelligence ... read more

  • Spray Dried Dispersions in Controlled Release Formulations

    The pharmaceutical industry continues to face significant challenges in formulating poorly water-soluble drugs, which constitute most new chemical entities (NCEs).1 Among various solubility-enhancing strategies, amorphous solid dispersion (ASD) is one of the most effective and versatile strategies for enhancing oral bioavailability. ASDs can ... read more

  • Sharper, Faster, Smarter: The Mass Spectrometry Advantage in Bioanalytical Testing

    Drug-plasma protein binding is a fundamental parameter in drug development that directly affects how a compound is distributed, metabolized, and excreted. Only a drug’s unbound fraction is pharmacologically active, so accurate measurements are essential for understanding efficacy and safety. This information also guides dosage design, predicts ... read more

  • Implementation of Contamination Control Strategy: Regulatory Evolution and Industry Adaptation Since 2023

    The implementation of Contamination Control Strategy (CCS) under the revised EU GMP Annex 1 has fundamentally transformed how pharmaceutical manufacturers approach sterile drug production. Since the guidelines became effective on August 25, 2023, the industry has grappled with translating theoretical regulatory requirements into practical ... read more

  • An Interview with Sabrina Graf- COO, Tenthpin

    I think the main developments have been the automation of complex processes, the improvement of data accuracy, and ensuring adherence to regulatory standards (GxP). This is what we hear from the top and leading global pharma companies as well when working with them. Vast datasets can be monitored in real-time, promptly identifying deviations or ... read more
Page
Page

Webinars

  • <<
  • >>